Target Name: OGFOD2
NCBI ID: G79676
Review Report on OGFOD2 Target / Biomarker Content of Review Report on OGFOD2 Target / Biomarker
OGFOD2
Other Name(s): 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 | 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (isoform 2) | 2-oxoglutarate and iron dependent oxygenase domain containing 2, transcript variant 2 | 2-oxoglutarate and iron dependent oxygenase domain containing 2 | OGFOD2 variant 2 | OGFD2_HUMAN

OGFOD2: Glutarate Metabolism and Drug Target

OGFOD2, also known as 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2, is a protein that plays a crucial role in the metabolism of glutarate, a crucial amino acid found in many cell types. Glutarate is a key precursor for the synthesis of glucose and other essential nutrients, and OGFOD2 is involved in the production and breakdown of glutarate in the body.

In addition to its role in metabolism, OGFOD2 has also been shown to play a number of other important functions in various cellular processes. For example, it has been shown to be involved in the regulation of cell death, cell signaling, and the transport of oxygen throughout the body.

Despite all of its important functions, OGFOD2 is currently a drug target and has not yet been studied extensively in depth. However, research into OGFOD2 and its potential as a drug target is ongoing, and it has the potential to lead to new treatments for a variety of diseases.

One of the key challenges in studying OGFOD2 is its complex structure. OGFOD2 is a protein that contains multiple domains, including an oxygen-dependent oxygenase domain, a catalytic domain, and a cytoplasmic domain. These domains give OGFOD2 a unique structure that is both compact and highly reactive.

In addition to its complex structure, OGFOD2 has also been shown to have a number of unique biological properties. For example, it is highly stable and has a long half-life in the body, which suggests that it plays an important role in the regulation of cellular processes. Additionally, OGFOD2 has been shown to be involved in the regulation of cell death, which suggests that it may have a role in the development of cancer.

Despite its many interesting properties, OGFOD2 is currently a drug target and has not yet been shown to be involved in any specific diseases. However, research into its role in the metabolism and biology of glutarate and its potential as a drug target is ongoing.

In conclusion, OGFOD2 is a protein that has many important functions in the body, including its role in the production and breakdown of glutarate. While more research is needed to fully understand its role in the world, it is clear that OGFOD2 is a protein of great interest and has the potential to lead to new treatments for a variety of diseases.

Protein Name: 2-oxoglutarate And Iron Dependent Oxygenase Domain Containing 2

The "OGFOD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OGFOD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OGFOD3 | OGFR | OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2